Nuwellis announces pricing of $2.0 million offering priced at-the-market under nasdaq rules

Minneapolis, july 24, 2024 (globe newswire) -- nuwellis, inc. (nasdaq: nuwe) (“nuwellis” or the “company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale of 469,340 shares of the company's common stock at a price of $4.24 per share of common stock in a registered direct offering priced at-the-market under nasdaq rules.
NUWE Ratings Summary
NUWE Quant Ranking